5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.
Acta Anaesthesiol Scand July 25, 2016 DOI: 10.1111/aas.12765 via PubMed
Summary
AI-generated from the abstractA novel designer drug, 5-MeO-DALT, has been identified as causing acute delirium and rhabdomyolysis in users. The report describes cases where ingestion of this substance led to severe adverse effects, including confusion, agitation, and muscle breakdown, highlighting the potential dangers of this emerging psychoactive compound.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Key finding | 5-MeO-DALT can cause acute delirium and rhabdomyolysis. |
Abstract
5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.